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African trypanosomes are sustained in the bloodstream of their mammalian hosts by their
extreme capacity for antigenic variation. However, for life cycle progression, trypanosomes
also must generate transmission stages called stumpy forms that are pre-adapted to
survive when taken up during the bloodmeal of the disease vector, tsetse flies. These
stumpy forms are rather different to the proliferative slender forms that maintain the
bloodstream parasitaemia. Firstly, they are non proliferative and morphologically distinct,
secondly, they show particular sensitivity to environmental cues that signal entry to the
tsetse fly and, thirdly, they are relatively robust such that they survive the changes in
temperature, pH and proteolytic environment encountered within the tsetse midgut.
These characteristics require regulated changes in gene expression to pre-adapt the
parasite and the use of environmental sensing mechanisms, both of which allow the
rapid initiation of differentiation to tsetse midgut procyclic forms upon transmission.
Interestingly, the generation of stumpy forms is also regulated and periodic in the
mammalian blood, this being governed by a density-sensing mechanism whereby a
parasite-derived signal drives cell cycle arrest and cellular development both to optimize
transmission and to prevent uncontrolled parasite multiplication overwhelming the host.
In this review we detail recent developments in our understanding of the molecular
mechanisms that underpin the production of stumpy forms in the mammalian bloodstream
and their signal perception pathways both in the mammalian bloodstream and upon entry
into the tsetse fly. These discoveries are discussed in the context of conserved eukaryotic
signaling and differentiation mechanisms. Further, their potential to act as targets
for therapeutic strategies that disrupt parasite development either in the mammalian
bloodstream or upon their transmission to tsetse flies is also discussed.
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INTRODUCTION
“This species . . . ..is characterised by showing two distinct forms-the
long and slender, and the short and stumpy. These are not sharply
divided from one another, but are interconnected by intermediate
forms, so as to form an unbroken series, or curve, from the shortest to
the longest.”
(Bruce et al., 1912)
“It has now been shown that the short forms are definitely capa-
ble of surviving in the transmitting host, but that does not in itself
exclude the intermediate and long forms from a similar development.
This apparently does not occur.”
“The shorter forms are those destined to carry on the cycle in the
transmitting host.”
(Robertson, 1912)
The presence of distinct morphological forms in the bloodstream
of mammalian hosts infected with African trypanosomes was rec-
ognized very early in the research into these parasites and the link
between this transition and disease transmission proposed soon
after (Robertson, 1912). However, the connection between the
different forms in the blood, termed “slender” and “stumpy” at
their morphological extremes, and parasite transmission poten-
tial remained controversial for nearly a century thereafter. This
was contributed to by the fact that the serial laboratory passage of
trypanosomes through rodent hosts prior to the development of
cryopreservation methods in the late 1950–1960s selected against
the development of stumpy forms. This was because stumpy
forms are irreversibly arrested in their cell cycle (Shapiro et al.,
1984) and require uptake by tsetse flies in order to recommence
cell division as midgut procyclic forms. The resulting laboratory-
adapted “monomorphic” forms are similar in appearance to the
slender-intermediate forms in natural infections and can differ-
entiate to procyclic forms in culture if exposed to high concen-
trations of citrate/cis-aconitate (CCA; Brun and Schonenberger,
1981; Roditi et al., 1989). This complicated the interpretation
of studies analysing the relative importance of stumpy forms in
transmission and it is only over the last 15 years that the particular
characteristics of stumpy forms that adapt them for transmission
have been recognized [reviewed in MacGregor et al. (2012)]. This
has been enabled by methods for the culture and transfection of
pleomorphic trypanosomes (i.e., those capable of stumpy forma-
tion) (Reuner et al., 1997; Engstler and Boshart, 2004) and the
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availability of tools to analyse development of trypanosomes in
the bloodstream quantitatively and in molecular detail (Reuner
et al., 1997; Dean et al., 2009; MacGregor et al., 2011). All of
these studies have reemphasized that stumpy forms fulfil a cru-
cial role in the life-cycle of the trypanosomes, assisting both
infection chronicity and transmission potential. Both of these
components are linked, since the development of arrested stumpy
forms in preparation for transmission also limits the ascending
parasitaemia, prolonging host survival (Figure 1). This provides
an elegant situation whereby the parasite creates an infection
dynamic that balances parasite survival through immune eva-
sion, host survival through restricted parasite virulence and an
adaptation for transmission and establishment in the tsetse fly
midgut (Lythgoe et al., 2007; Gjini et al., 2010; MacGregor et al.,
2011, 2012). This infection dynamic is established by the ability
of the trypanosomes to monitor their density in the mammalian
bloodstream using a system in some ways analogous to the quo-
rum sensing (QS) systems employed by bacteria. However, whilst
those systems are often exploited by microbes to share resources
or to co-operate to invade or colonize their current environment
(Diggle et al., 2007), trypanosomes are also exploiting environ-
mental information to prepare for their colonization of a new
environment.
In this review we detail the several mechanisms and processes
that trypanosomes exploit to ensure their capacity for trans-
mission through the development of stumpy forms. We firstly
discuss the recent analyses of gene expression and protein changes
that accompany the transition from proliferative slender forms to
arrested stumpy forms. Secondly, we describe how the parasite
regulates its production of transmission stages by density sensing
mechanisms in the mammalian bloodstream. Thirdly, we detail
how the parasite surface is adapted for environmental sensing and
survival and for transmission of the parasite and, fourthly, how
entry into the tsetse midgut is perceived by the parasite and the
signal transduced to initiate the development to procyclic forms.
Finally, we discuss how the developmental transitions that the try-
panosome undergoes in preparation for, or during, transmission
can be targeted in therapeutic approaches that act both to limit
virulence and to prevent disease spread.
GENE EXPRESSION REGULATION DURING THE SLENDER TO
STUMPY TRANSITION AS A PRE-ADAPTATION FOR
DIFFERENTIATION
Overlaid onto the organization of the African trypanosome
genome into multi-gene transcription units (Clayton, 2002) is
its developmental regulation, with large scale changes in gene
expression being observed during the parasite life cycle in order to
adapt to the different conditions encountered in the mammal and
insect environments. Recently, three different studies analysed the
expression profile of mRNAs between bloodstream forms and
procyclic forms utilizing pleomorphic slender forms, in vivo gen-
erated stumpy forms (differentiated from slender forms) and cells
undergoing synchronous differentiation from stumpy to procyclic
forms (Jensen et al., 2009; Kabani et al., 2009; Nilsson et al., 2010).
Despite the different approaches used by the three laboratories
[i.e., microarrays (Jensen et al., 2009; Kabani et al., 2009) vs.
FIGURE 1 | Events accompanying the development of trypanosomes in
their mammalian host and upon transmission to tsetse flies. In the
bloodstream, slender forms proliferate to increase the parasitaemia. Cell
density is perceived via the release and detection of stumpy induction factor,
this leading to changes in the morphology and gene expression of the
parasites as they undergo development to stumpy forms. The stumpy forms
are adapted to short term survival in the blood and transmission to tsetse
flies. When taken up in a bloodmeal, stumpy forms perceive their new
environment and then undergo morphological, metabolic and gene
expression changes as they differentiate to procyclic forms. These colonize
the tsetse midgut where, after further development and migration to the
tsetse salivary glands, they become infective to new mammalian hosts.
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spliced leader trapping (Nilsson et al., 2010) or biological sam-
ples obtained from immunocompromised mice (Kabani et al.,
2009; Nilsson et al., 2010) vs. rats (Jensen et al., 2009)], generally
complementary results were achieved showing that, contrary to
what had been previously suggested, a quite high percentage of
T. brucei genes are differentially expressed between developmen-
tal forms in the blood and the tsetse midgut [25–40% of all
genes, according to Jensen et al. (2009); Nilsson et al. (2010)].
Within these studies a number of group comparisons generated
outcomes relevant to the developmental or environmental reg-
ulation of gene expression in the parasites. For example, Jensen
et al. observed, surprisingly, that cultured bloodstream forms and
in vivo derived slender forms showed similar expression pro-
files despite their predicted biological differences, whereas the
distinctions between logarithmic and stationary procyclic forms
were more pronounced (Jensen et al., 2009). Moreover, from
all three studies it was clear that the stumpy forms constitute a
pre-adaptation required for transmission, with these cells having
already undergone many changes in expression when compared
to slender forms.
Overall, the most highly regulated transcripts between slen-
der and stumpy forms are those involved in metabolism, cell
structure, protein transport, proteolysis and translation, as well as
many transcripts with currently unknown function. As expected,
slender forms express significantly more ESAGs and GRESAGs
(both usually, but not always, found in telomeric and subtelom-
eric regions together with the VSGs) than stumpy forms (Kabani
et al., 2009), with the exception of several ESAG9s that are known
to be up-regulated in stumpy forms and have been suggested to be
involved in interaction with the external environment (Barnwell
et al., 2010). Consistent with slender forms being proliferative
and stumpy forms being cell-cycle arrested quiescent forms, his-
tones, DNA replication/repair and translation-related transcripts
were found to be up-regulated in slender compared to stumpy
forms (Kabani et al., 2009). Other transcripts showing higher
expression in the proliferative forms included those associated
with the cytoskeleton, especially those related to the flagellum, as
well as transcripts involved in metabolism, predominantly those
which are localized to the glycosome or are involved in glucose
uptake and glycolysis (i.e., glucose transporter THT1 and PGKC).
Contrasting with this, procyclins and PAD (Proteins Associated
with Differentiation) family members involved in CCA-mediated
differentiation, (Dean et al., 2009) are up-regulated in stumpy
forms as is MSP-B, associated with the VSG cleavage necessary
for the change of surface coat upon differentiation to the insect
form (Gruszynski et al., 2006). Further, transcripts involved in
cytoskeletal remodeling and membrane protein and lipid biosyn-
thesis are increased in stumpy forms, perhaps contributing to
the more robust characteristics of the transmissible forms (Nolan
et al., 2000) and their need for rapid membrane rearrange-
ment upon entry into the tsetse fly. It has also been known for
some time that lysosome activity is enhanced in stumpy forms
(Brickman and Balber, 1994), so the observed up-regulation of a
chloride channel transcript in these forms (Kabani et al., 2009)
could be explained by its role in the maintenance of lysosomal
pH. Other transcripts elevated in stumpy forms are RNA heli-
cases related to RNA processing and two zinc-finger proteins
that have been demonstrated to be important in differentiation
control (Hendriks et al., 2001; Hendriks and Matthews, 2005;
Paterou et al., 2006) and that are apparently involved in the reg-
ulation of transmission stage transcripts (Walrad et al., 2012).
Finally, metabolic enzymes, such as trypanosome alternative oxi-
dase and fructose-2, 6-biphosphatase, as well as components of
the cytochrome oxidase complex and other mithochondrial genes
such as ATP synthase subunits and NADH dehydrogenase sub-
units are up-regulated in stumpy forms (Jensen et al., 2009;
Kabani et al., 2009; Nilsson et al., 2010). All of these observa-
tions confirm the pre-adaptation of stumpy forms to the more
complex metabolic requirements of life in the tsetse fly, which
involves a well developed mitochondrion with functional Krebs
cycle enzymes, respiratory chain and oxidative phosphorylation
enzymes and an increased reliance on the oxidation of amino
acids like proline. More recently, an analysis of the transcriptome
of slender, intermediate and stumpy forms (Capewell et al., 2013)
has shown that many of the changes observed between slender
and stumpy forms are already present in the intermediate forms,
highlighting that the preparation for transmission occurs early in
the development of stumpy forms in the bloodstream, long before
the dramatic environmental changes that accompany entry into
the tsetse midgut are encountered. This developmental program-
ming is therefore, a response to the parasites own density-sensing
signal, and not a predominently environmental response, such as
could be generated by the thermal stress or glucose depletion that
occurs upon tsetse uptake.
As well as during the transition from slender to stumpy forms,
transcriptome changes accompany the synchronous differentia-
tion from stumpy forms to procyclic forms (Kabani et al., 2009;
Queiroz et al., 2009). For example the transcripts for ESAG2,
ESAG11 and the glucose transporter THT1 are rapidly and pro-
gressively down-regulated, whilst EP2 and EP3 procyclin tran-
scripts are up-regulated, preparing the surface coat for the insect
stage. Re-entry into DNA synthesis around 8–10 h through differ-
entiation (Matthews and Gull, 1994) is preceded by the induction
of histone mRNAs 6 h after exposure to CCA. The activation
of translation between 1 and 6 h (Capewell et al., 2013) is also
accompanied by an enrichment of mRNAs for different nucleolar
proteins and ribosomal components (re-entry into prolifera-
tion occurs at 8–19 h into the differentiation programme). The
metabolic adaptation to the procyclic form is also confirmed by
down-regulation of bloodstream form enriched phosphoglycer-
ate kinase C mRNA and the up regulation of the procyclic form
enriched PGKB (Gibson et al., 1988), whilst mitochondrial acti-
vation is accompanied by the up-regulation of the components of
the cytochrome-oxidase complex soon after the initiation of the
differentiation process (Kabani et al., 2009).
From all these studies, it seems clear that changes during
the life cycle are accompanied by significant changes in gene
expression at the mRNA level, but what is happening to the
corresponding proteome? Here the changes appear qualitatively
and quantitaviely different, with protein levels also showing a
greater amplitude of change during development. A recent study
by Gunasekera et al. used a combination of SILAC (Stable Isotope
Labelling of Amino acids in Cell culture) and mass spectrome-
try to determine the differences in protein abundance between
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slender, stumpy and procyclic forms (Gunasekera et al., 2012).
The study was able to detect 30% of the total proteome and,
although there was some bias against very small proteins, pro-
teins containing more than one transmembrane domain or very
basic proteins, achieved good coverage across the genome. An
interesting feature of this study was that around 30% (depending
on expression parameters) of genes showed relatively low correla-
tion between RNA and protein levels, even for some transcripts
with a robust expression profile. This contrasts with a similar
SILAC analysis of bloodstream and procyclic forms carried out by
Urbaniak et al. (2012), that found a good correlation with tran-
scriptome profiles (albeit with a greater dynamic range in the pro-
teome studies). Nonetheless, analysis of the three life cycle stages
(slender, stumpy, procyclic) by Gunasekera et al. showed major
protein changes during the transition from slender to stumpy
forms, with more than 500 proteins being increased in stumpy
forms. Of these, proteins showing ≥2-fold increase in stumpy
forms belongedmainly to the GO (Gene Ontology) terms: plasma
membrane, peroxisome, nucleus, microtubule, lysosome, glyco-
some, andmitochondrion. Supporting the identified changes, this
study showed good correlation with previous data for the lev-
els of the bloodstream form enriched alternative terminal oxidase
(TAO) (Chaudhuri et al., 1995) and for the stumpy-specific PAD1
transporter family involved in parasite differentiation (Dean et al.,
2009). Moreover, the assembly of oxidative phosphorylation com-
plexes III and IV was suggested as one of the final activation
steps for energy production in the insect form, being present only
in procyclic forms, whilst complexes I, II, and V were already
present in stumpy forms. Finally, and supporting previous data
obtained with the splice leader trapping approach by the same
group (Nilsson et al., 2010), the study showed that one gene
can have different protein products differing in their N-terminus,
highlighting alternative splicing as a mechanism to create protein
diversity.
These proteomic studies are generally in good agreement
with a more recent analysis by Digital Serial Analysis of Gene
Expression (Digital-SAGE) of the transcripts enriched in the
polysomal fraction of slender and stumpy forms (Capewell et al.,
2013). This analysis was designed to identify transcripts that
might escape the overall translational repression characteristic of
stumpy forms, and pointed to mitochondrial, ribonuclear com-
plexes and macromolecular biosynthetic related transcripts being
amongst those more elevated during development to stumpy
forms. Moreover, the global translational quiescence of stumpy
forms was supported by the depletion of mRNAs encoding ribo-
somal proteins in the stumpy polysomal material. However, only
a few of the polysome-enriched stumpy transcripts showed an
in vitro differentiation phenotype when analysed by genome wide
RNAi analysis (Alsford et al., 2011) indicating a role distinct from
the process of differentiation per se, with an alternative potential
role in cell viability or development in the tsetse fly midgut.
Since gene expression in African trypanosomes is regulated at
multiple levels (mRNA stability, translation and protein stabil-
ity), it is important to understand the mechanisms involved in
the control of these processes. In trypanosomatids, the develop-
mental regulation of mRNA abundance has been primarily linked
to the presence of regulatory sequences and structures located in
the 3′untranslated region (3′UTR) (Clayton and Shapira, 2007)
but that can also be present in the 5′UTR (Pasion et al., 1996;
Mahmood et al., 2001). As mentioned earlier, alternative splicing
has been also identified as a further potential regulatory step, with
a total of 676 genes being observed to have changes inmajor splice
site usage between developmental forms (Nilsson et al., 2010).
These regulatory signals within untranslated regions are then
acted upon by RNA binding proteins that operate to positively
or negatively regulate the mRNA transcript’s expression. Indeed,
a large number of potential RNA binding proteins are encoded in
the trypanosome genome (De Gaudenzi et al., 2005; Kramer et al.,
2010; Kramer and Carrington, 2011). With regards to the control
of developmental gene expression, procyclin genes are the best
characterized, being regulated during early development in the
tsetse midgut (Hehl et al., 1994; Furger et al., 1997; Walrad et al.,
2009). These genes have similar, but distinct, 3′UTRs (Vassella
et al., 2001a) and their differential expression is controlled by
trans-acting proteins that include the small CCCH protein ZFP3,
which specifically associates with EP1 and GPEET mRNA, rather
than EP2 and EP3mRNA, and promotes gene expression through
association with the translational apparatus (Paterou et al., 2006;
Walrad et al., 2009). Interestingly, a global analysis of the other
mRNAs that are also stabilized by ZFP3 showed enrichment for
mRNAs that were predominantly abundant in stumpy forms
(Walrad et al., 2012), emphasing the importance of this protein
in transmission events.
As highlighted above, there is a global decrease in protein syn-
thesis during the transition from the slender to stumpy form
(Brecht and Parsons, 1998; Capewell et al., 2013) and yet a
number of genes escape this global repression of expression
to be upregulated in stumpy forms. In a search for regulatory
regions controlling transmission-stage gene expression Kabani
et al. (2009) identified, using an oligonucleotide frequency scor-
ing algorithm, two related hexanucleotide sequences (TCTTAC
and TTCTTA) that were over-represented in the 3′UTR of tran-
scripts predicted to be enriched in stumpy forms. Although no
functional analysis of these motifs has been performed, the first
of these showed a positional bias 150–200 nt downstream from
the gene stop codon. To more functionally define regulatory
regions, two recent studies have focused on the detailed identi-
fication of sequences and structures involved in the control of
two validated stumpy-specific transcripts, encoding PAD1 and
an ESAG9 copy. Utilizing CAT reporter assays in pleomorphic
trypanosomes, it was demonstrated that both PAD1 and ESAG9
contain regulatory regions in their 3′UTRs that repress expres-
sion in the slender life stage and alleviate repression in the stumpy
form (MacGregor and Matthews, 2012; Monk et al., 2013). For
PAD1, the distal end of the 3′UTRwas found to contain anmRNA
silencing element that represses both mRNA and protein expres-
sion. However, specific deletion of this region did not alleviate
protein expression silencing, suggesting the additional involve-
ment of proximal regions within the 3′UTR. This was confirmed
by the independent integration of the PAD1 proximal or distal
3′UTR regions into the 3′UTR of a constitutively expressed gene,
which resulted in no repression at themRNA level for the reporter
gene. Nevertheless, repression was observed at the protein level,
suggesting that protein control may be more stringent, consistent
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with the fact that PAD mRNA is elevated early in intermediate
forms (MacGregor et al., 2011, 2012) whilst protein expression
is only found in fully differentiated stumpy forms (Dean et al.,
2009). In the ESAG9 3′UTR a regulatory region of just 34 nt was
defined as a bifunctional element responsible for both positive
and negative regulation depending on the developmental stage of
the parasite (Monk et al., 2013). This element regulated mRNA
levels and, in the context of the complete ESAG9 3′UTR, also
protein levels. The simplest model for this regulation implicated
a negative regulator binding this element in slender forms and
repressing gene expression, whilst in stumpy forms this would
be replaced by a positive regulator alleviating the repression of
gene expression. Unlike PAD1, insertion of this short regulatory
element into the 3′UTR of a constitutively expressed gene had
a strong effect on mRNA only, suggesting that other sequences
within the ESAG9 3′UTR might also contribute to the regula-
tion of translation, for example by stabilizing the association of
positive translational regulators. Hence, whilst no similarity in
the sequence elements was found between the ESAG9 and PAD1
3′UTRs, in both cases stringent regulation at both the mRNA
and protein level was observed to control their exclusive expres-
sion in the stumpy form. This stringency of regulation is likely to
be important for ensuring the appropriate timing of the expres-
sion of genes involved in cell-cycle arrest or transmission during
programmed development from the slender to stumpy form.
SIGNALING MECHANISMS THAT GOVERN STUMPY
FORMATION IN THE MAMMALIAN BLOODSTREAM
The progression of trypanosome infections in the mammalian
host follows a wave-like pattern, at least early on, with the actively
dividing slender forms dominating the ascending phase leading
up to the peak, followed by G1/G0 arrest and differentiation to
the stumpy forms. While the interplay of host immune factors
and the antigenic variation of the parasite play a major role in
the waves of parasitaemia, the slender to stumpy transition is
an important additional contributor (Lythgoe et al., 2007; Gjini
et al., 2010; MacGregor et al., 2011), primarily dictated by par-
asite density (Reuner et al., 1997). Indeed, pleomorphs reach a
threshold parasitaemia before they undergo differentiation (Seed
and Sechelski, 1989), and in vitro this is linked to the parasite
number regardless of the culture seeding density (Reuner et al.,
1997). Since monomorphic strains continue to grow to higher cell
densities under similar growth conditions as the arrested pleo-
morphs a limitation in medium components seems unlikely and,
indeed, nutrient replacement fails to restore the growth of dense
pleomorph cultures (Hesse et al., 1995). Instead, early tentative
evidence for a secreted factor controlling parasite growth was pro-
vided by the observation that plasma from infected animals at
peak parasitaemia could inhibit trypanosome proliferation (Seed
and Sechelski, 1989), whereas in vitro studies provided further
support for the accumulation of a parasite-derived product able
to induce stumpy formation (Reuner et al., 1997; Vassella et al.,
1997). This density dependent transition from long slender forms
to short stumpy forms is reminiscent of the QS mechanisms
observed in several prokaryotes and essentially comprises three
main components- the signaling molecule(s), the receptor(s) that
perceive the cue(s) and the downstreammodulators that relay the
signal, triggering a series of changes that ultimately bring about
differentiation.
In the case of African trypanosomes, the cells sense the
increase in their numbers and consequently cease cell division.
This ensures the parasite numbers do not overwhelm the host,
as can occur when infections are initiated with differentiation-
incompetent monomorphic lines (Turner et al., 1995). The devel-
opment of a plate-based technique for growing pleomorphic
strains in vitro (Vassella and Boshart, 1996), led to the discov-
ery that a soluble, low molecular weight factor, termed Stumpy
Induction Factor (SIF) was able to provide the signal for differ-
entiation (Reuner et al., 1997; Vassella et al., 1997), ruling out a
major contribution from the host and highlighting the signal as
a parasite-intrinsic entity. Although monomorphs are incapable
of differentiation, they do produce SIF (Vassella et al., 1997),
and are therefore “signal-blind,” a necessary requirement for their
selection in a background population of parasites producing SIF
(MacGregor et al., 2012).
In terms of intracellular signaling, the addition of parasite-
conditioned media (containing SIF) causes an increase in cAMP
levels in pleomorphs (Vassella et al., 1997). This is consistent with
the 2–3-fold increase in intracellular cAMP observed when early
log phase slender parasites reach peak parasitaemia in rodents,
which is followed by a decrease in the cAMP levels upon appear-
ance of intermediate and stumpy forms (Mancini and Patton,
1981). This suggested cAMP might act as a second messenger
conveying the SIF signal. Moreover, further support for a role of
cAMP in development was provided by the observation that a
cell permeable analog of cAMP (8-pCPT-2′-O-Me-cAMP) pro-
moted G1/G0 arrest in pleomorphs on plates (Vassella et al.,
1997), whereas procyclic cells were quite insensitive to high con-
centrations (up to 1mM or more) of various cell-permeable
cAMP derivatives (Oberholzer et al., 2007). However, unlike
Plasmodium falciparum, where differentiation to transmissible
gametocytes is mediated by cGMP (Hopp et al., 2012), the slen-
der to stumpy transition in trypanosomes now appears not to
be a conventional cyclic nucleotide response but is restricted to
cell permeable cAMP analogs (Vassella et al., 1997). Furthermore,
the hydrolysis resistant analog of cAMP (Sp-8-pCPT-2′-O-Me-
cAMPS) is not anti-proliferative for monomorphic slender forms
whereas the degradation products of cAMP, namely AMP and
adenosine, have a more potent effect, indicating that these
molecules are likely to be the key players in the signaling cascade
rather than cyclic nucleotides (Laxman et al., 2006) (Figure 2).
Supporting this, knockdown of the T.brucei PDEB family, which
causes an increase in the levels of intracellular cAMP, failed to
promote differentiation (Oberholzer et al., 2007) despite the abil-
ity of etazolate, a phosphodiesterase (PDE) inhibitor to induce
this transition (Vassella et al., 1997), a discrepancy possibly due
to the proposed lack of specificity of etazolate for trypanoso-
mal PDEs (Laxman et al., 2006). Further evidence for cAMP
not being the direct modulator of differentiation was recently
provided by the observation that the levels of TbTOR4 protein
(whose loss of function triggers the appearance of stumpy-like
forms, see below) decreased when parasites were exposed to
8-pCPT-2′-O-Me-cAMP or 8-pCPT-2′-O-Me-AMP but not Sp-
8-pCPT-2′-O-Me-cAMPS (Barquilla et al., 2012). Combined this
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FIGURE 2 | Response of monomorphic slender cells to cell permeable
analogs of cAMP/AMP.Monomorphic slender cells have lost the capacity to
generate stumpy forms in vivo, showing a reduced ability to respond to stumpy
induction factor. However, when exposed to cell permeable analogs of cAMP or
AMP these cells stop proliferation and express some, but not all, characteristics
of stumpy forms, namely proliferation arrest, increased capacity for
differentiation to procyclic forms and the increased expression of somemRNAs
enriched in stumpy forms. This is not a cAMP-mediated response because
hydrolysable but not non-hydrolysable cAMP analogs induce the transition and
cell permeable AMP is considerably more potent than cell permeable cAMP.
Hence the cell permeable cAMP is likely metabolized to cell permeable AMP to
elicit the production of stumpy-like forms.
points to a non-canonical intracellular signaling pathway operat-
ing to regulate stumpy formation, that does not involve cAMP as
a second messenger.
To date no component of a signaling pathway that has a
direct role in promoting stumpy formation has been identified.
However, genes whose loss of function triggers quiescence (and
hence are differentiation inhibitors) have provided some molecu-
lar insight into the signaling cascade. For example, the deletion
of a Zinc finger kinase (ZFK) in pleomorphs reduced growth
and also increased the rate of the slender to stumpy transition,
albeit only in vitro (Vassella et al., 2001b). Similarly, knock out
of a mitogen activated protein kinase homolog, TbMAPK5, gave
a similar phenotype, with the exception that stumpy formation
in vivo was also accelerated (Domenicali Pfister et al., 2006).
Whilst neither the ZFK norMAPK knockouts could induce differ-
entiation in monomorphs, deletion of the TOR kinase member,
TbTOR4, stimulated monomorphs to generate stumpy-like forms
(Barquilla et al., 2012), positioning this molecule downstream of,
or on a distinct pathway to, the other inhibitors.
The evidence for the existence of the SIF signaling factor(s)
itself remains circumstantial. It is believed to be a small (<500
Da), soluble and filterable factor, distinguishing it from other
parasite communication systems, such as the secreted vesicular
exosomes recently described for Plasmodium parasites (Mantel
et al., 2013; Regev-Rudzki et al., 2013). Although the identity
of SIF has eluded us to date, a recent intriguing finding on
the ability of derivatives of the differentiation inducing factor
(DIF) from Dictyostelium discoideum to reduce proliferation of
T. cruzi parasites in vitro as well as in vivo (Nakajima-Shimada
et al., 2013) suggests that there might be some conservation of
eukaryotic QS processes. Until recently, one of the major obsta-
cles to determining the molecular nature of SIF was the lack of
a robust marker for stumpy formation that could enable high
throughput screens for stumpy inducers. However, the discovery
of PAD1 as a stumpy-specific marker (Dean et al., 2009) and the
development of reporter lines using this marker (MacGregor and
Matthews, 2012), now enables activity-guided assays for screening
components of conditioned medium, assisting the purification
of SIF.
ADAPTATIONS FOR SURVIVAL IN THE MAMMALIAN HOST
BY STUMPY FORM TRYPANOSOMES AND SIGNALING
EVENTS UPON TRANSMISSION
SURFACE MOLECULES
Once stumpy forms are generated from slender forms they are
irreversibly arrested and have a limited lifespan in the blood-
stream (Turner et al., 1995). Nonetheless, to maximize their
potential for transmission, stumpy form trypanosomes exhibit
a number of adaptations that both prolong their survival in the
mammalian bloodstream (increasing their probability of uptake
by tsetse flies) and promote their viability upon entering the tsetse
midgut.
Perhaps the most obvious survival mechanism employed by
trypanosomes in the mammalian blood is their expression of
a variant surface glycoprotein, providing protection against the
alternative pathway of complement activation (Ferrante and
Allison, 1983) and, through antigen variation, antibody-mediated
killing. This protection extends only to trypanosomes that have
changed their surface antigen coat and is therefore, probably
not available to non-proliferating stumpy forms. Nonetheless
stumpy forms do show a particular adaptation allowing their
preferential survival when exposed to increasing titres of antigen-
specific antibody during a wave of infection. This process removes
the bound antibodies from the surface of the parasite by using
hydrodynamic flow forces (Engstler et al., 2007). Specifically,
the flagellum of trypanosomes, attached along the cell body,
propels the parasite anteriorly. This causes the movement of
bound immune complexes by hydrodynamic drag forces back-
wards toward the posterior flagellar pocket. Using cell-surface
VSG labeled with a membrane-impermeable blue-fluorescent
dye, the majority of immunoglobulin bound to VSG was found
to be transported to the lysosome, where the immunoglobulin
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was degraded, whereas the VSG was recycled to the cell surface.
The directional movement of the immunoglobulin-VSG com-
plex toward the posterior end of the cell and its subsequent
rapid endocytosis provides a very efficient mechanism to clear
immune complexes from the cell surface and is twice as rapid for
stumpy forms as for slender forms (Engstler et al., 2007). Hence,
this phenomenon could contribute to the greater resistance of
stumpy forms to antibody-mediated killing than slender forms
(McLintock et al., 1993), allowing the stumpy forms to predom-
inate at peak parasitaemia and extending the period at which the
infection is transmissible to tsetse flies.
Other molecules at the parasite surface and within the flag-
ellar pocket show developmental regulation during develop-
ment between slender and stumpy forms. Whilst ESAG9 is
upregulated early during stumpy formation, as detailed earlier,
the haptoglobin-haemoglobin receptor in the flagellar pocket
is downregulated (Vanhollebeke et al., 2010). This molecule is
involved in haptoglobin-haemoglobin uptake, which may no
longer be needed in the quiescent stumpy form. However, it
might also represent a protection mechanism for transmission
stages against TLF1, since the haptoglobin haemoglobin recep-
tor is the route for the uptake of the trypanosome lytic factor
in human serum (Vanhollebeke et al., 2008). Since the resis-
tance to TLF is mediated in Trypanosoma brucei rhodesiense by
an expression site component, SRA (Xong et al., 1998), and
expression site transcription is strongly down regulated in stumpy
forms (Amiguet-Vercher et al., 2004), the downregulation of the
haptoglobin-haemoglobin receptor in stumpy forms could pre-
vent TLF1-mediated killing when SRA production is reduced.
TLF2-mediated killing would remain possible, however, unless
parasites were sequestered in the tissues or lymphatics, as has been
suggested for metacyclic forms (Pays et al., 2006).
At the level of mRNA transcripts, the abundant invariant sur-
face glycoproteins (ISGs) 65 and 75 [present at ∼70,000 and
50,000 copies, respectively, (Ziegelbauer and Overath, 1992)] are
also down regulated in stumpy forms with respect to slender
forms (Nilsson et al., 2010). ISG proteins have type I trans-
membrane topology and intercalate with VSG on the surface
(Leung et al., 2011). Although no identified function has been
assigned for these surface proteins, ISG75 was recently identified
in a genome-wide RNAi-screen to mediate the uptake of the try-
panocidal drug suramin (Alsford et al., 2012). ISG65 and ISG75
have been found to be present at the surface and endosomalmem-
branes and are turned over more rapidly than VSGs in a process
involving ubiquitination of lysine residues in their cytoplasmic
domains. Specifically, ISG65 has been shown to be ubiquitinated
on residues K3 and K4 of the cytoplasmic tail, with mutation of
these residues significantly increasing the protein half life (Chung
et al., 2008). ISG75 is also ubiquitynated in T. brucei and the
absence of cytoplasmic lysine residues renders the protein inca-
pable of modification by ubiquitin and consequently stabilized
(Leung et al., 2011).
As well as proteins at the cell surface membrane and flagel-
lar pocket, it has been hypothesized that the parasite flagellum
functions as a signaling organelle for integrating host-derived and
parasite-derived signals and these could contribute to develop-
ment both in the bloodstream and upon transmission to tsetse
flies. For example, proteins involved in cyclic nucleotide signaling,
Ca2+ signaling and phospho-signaling pathways are anchored to
the T. brucei flagellum skeleton (Wu et al., 1994; Oberholzer et al.,
2007; Smith et al., 2009). T. brucei calflagins Tb17, Tb24, Tb44
are all calcium sensors that associate with the flagellar membrane
in a calcium-dependent and palmitoylation-dependent manner,
and although their precise function its not clear, a role for these
proteins in host survival and immune evasion has been described
(Emmer et al., 2010). Monomorphic calflagin-deficient para-
sites exhibit a normal growth rate in vivo during the first week
post-infection, but subsequently parasite numbers decrease to
undetectable levels, followed by the emergence of a parasite pop-
ulation expressing alternative VSGs. This phenotype does not
involve any failure in surface-bound antibody clearance or par-
asite motility, indicating that calflagins could promote parasite
resistance to early host immunity. In a recent study, by perform-
ing flagellum purification, combined with affinity purification of
surface exposed proteins and multidimensional protein identifi-
cation technology (MudPIT), many novel and already identified
proteins were found on the flagellum surface (Oberholzer et al.,
2011). This included receptor-like proteins with a large extracel-
lular domain, that could be suitable for binding host ligands, con-
nected to an intracellular signaling module, for example a kinase
domain, supporting the idea that the flagellum might be able to
sense the environment and transmit signals inside the cell to assist
their adaptation, differentiation or survival in the bloodstream.
ADENYLATE CYCLASE SIGNALING IN THE MAMMALIAN
BLOODSTREAM
The T. brucei genome encodes more than 80 adenylate cyclases
(ACs), many of which are at the cell surface (Alexandre et al.,
1996; Bridges et al., 2008). The prototype gene of this family,
termed ESAG4, is part of VSG expression sites and so bloodstream
stage-specific, unlike the family of related genes, GRESAG4 (genes
related to ESAG4) which are positioned outwith expression sites
and constitutively transcribed throughout the life cycle of the
parasite.
The ACs of T.brucei share a similar structure, with a large
extracellular domain (900 amino acids) and a conserved intra-
cellular catalytic domain (around 350 amino acids) separated by
a single transmembrane domain; dimerization of the catalytic
domain is required for activity. Although the basal cellular cyclic
adenosine monophosphate (cAMP) concentration is extremely
low, stress, such as acid treatment or osmotic lysis, activates ACs
by up to two orders of magnitude (Rolin et al., 1996, 1998; Nolan
et al., 2000). Recently, ESAG4 activity has been shown to be cru-
cial to regulate processes involved in the early establishment of
the parasitaemia in the host (Salmon et al., 2012b). By overex-
pressing a catalytically dead mutant (DNc) of ESAG4, total AC
activity was reduced by 50% and transient growth retardation and
cytokinesis abnormalities in culture were seen, subsequently com-
pensated by an upregulation of GREG4.1 (Salmon et al., 2012a).
In mice, however, the parasitaemia of DNc cells was considerably
reduced, and the host survival time was extended. After analysing
immune modulators affecting trypanosome infection such as
tumor necrosis factor alpha (TNF-α), Interferon gamma (INF-γ),
and Nitric oxide (NO), it was shown that TNF-α is crucially
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involved in controlling the early trypanosome parasitaemia and
that the trypanosomal ACs inhibited TNF-α synthesis in liver
myeloid cells by activating the myeloid cell PKA (Salmon et al.,
2012b). Apparently, therefore, the trypanosome adenylyl cyclases
inhibit the innate response of the host by shutting down TNF-α
synthesis, helping the infection to establish.
As mentioned earlier, a peak in the activity of AC has also
been linked to the transition from the slender form to the stumpy
forms (Mancini and Patton, 1981; Vassella et al., 1997); slen-
der cells increase their intracellular cAMP concentration until
they reach peak parasitaemia, and then it decreases as the tran-
sition to intermediate and short stumpy forms commences.
Interestingly, ESAG4 protein levels are reduced in the stumpy
form by 93% compared to slender forms, although ablation by
RNAi of the ESAG4+ESAG4L subfamily does not modify the
slender to stumpy differentiation (Salmon et al., 2012a).
AC activity is also activated by incubation of slender forms at
pH 5.5 (perhaps mimicking their activation upon macrophage
uptake early in infection), but no similar effect is seen in stumpy
forms (Nolan et al., 2000). This correlates with the greater tol-
erance to high extracellular H+ concentration of stumpy forms
compared to slender forms, reflecting that stumpy cells are able
to maintain a constant cytoplasmic pH. Nonetheless, during the
differentiation from stumpy to procyclic forms a significant but
transient increase in cyclase activity is observed at around 6 h into
differentiation and after the initiation of cell proliferation (Rolin
et al., 1998). However, since the first peak in AC activity occurs
after the transformation into procyclics begins, it is unlikely that
the rise in cAMP generated is involved in the early differentiation
events in the tsetse.
SURFACE MOLECULES AND SIGNALING EVENTS AS STUMPY FORMS
ENTER THE tsetse MIDGUT
There are two known ways that VSG is released from the try-
panosome cell surface during differentiation from stumpy to
procyclic forms, glycophosphatidyl inositol (GPI) hydrolysis and
endoproteolysis. Slender and stumpy trypanosomes contain an
endogenous GPI phospholipase C (GPI-PLC) that is capable of
hydrolyzing the GPI anchor found on VSG, but not procyclin.
GPI-PLC is reported to be located exclusively in a linear array
on the outside of the flagellar membrane, close to the flagel-
lar attachment zone (Hanrahan et al., 2009). Deletion of both
the GPI-PLC gene and a Zn2+-metalloprotease (TbMSP-B) gene
prevents the differentiation of monomorphic bloodstream forms
into procyclic forms, although the cells remain viable for sev-
eral days (Grandgenett et al., 2007). In stumpy cells exposed
to the differentiation triggers CCA, MSP-B mRNA and pro-
tein levels are upregulated, this occurring concurrently with the
onset of proteolytic release of VSG (Gruszynski et al., 2006). In
contrast, GPI-PLC mRNA levels quickly decrease after differenti-
ation is induced. Protein levels decrease subsequently, although
a dramatic loss of enzyme only occurs after the onset of cell
division (most probably by cell dilution). Hence the combined
action of GPI-PLC and MSP-B operate to enable the rapid and
synchronous loss of VSG from differentiating stumpy form try-
panosomes that occurs ∼6 h after the initiation of differentiation
(Gruszynski et al., 2006).
Two genes encoding surface carboxylate transporters, PAD1
and PAD2, have also been shown to be expressed at the surface of
stumpy form T. brucei and important for the initiation of differ-
entiation. These proteins have differential expression through the
life cycle of the parasites, being absent in the replicative slender
form and upregulated in the stumpy (PAD1 and PAD2) and pro-
cyclic form (PAD2) (Dean et al., 2009). By RNAi targeting both
genes it was shown that they are not required for either stumpy
formation or survival, but that they are required to perceive CCA
at physiological concentrations to enable differentiation from
stumpy into procyclic cells. PAD2 was also demonstrated to be
released to the cell surface at 20◦C, thereby demonstrating a
redistribution of the transporter in response to cold shock. The
expression profile and differential trafficking of the PAD pro-
teins contributes to appropriate developmental responses in two
ways (MacGregor and Matthews, 2010). Firstly, by being absent
on slender forms but present on stumpy forms, sensitivity to the
differentiation signals is restricted to the transmission-adapted
stage. Second, the elevation of PAD2 at low temperature ensures
that only those parasites that enter the arthropod midgut can
detect and respond to the signal. This signal is then relayed
via a phosphatase-signaling cascade to initiate the differentiation
events that allow colonization of the tsetse midgut.
SIGNAL TRANSDUCTION OF THE DIFFERENTIATION SIGNAL
UPON ENTRY INTO THE tsetse FLY
Despite the detailed in silico analysis of the TriTryp kinome
(Parsons et al., 2005) and phosphatome (Brenchley et al., 2007),
a coherent assembly of environmental signaling pathways in
trypanosomes is almost entirely missing. One exception is the
protein phosphatase cascade that regulates differentiation from
bloodstream stumpy forms to vector-adapted procyclic forms.
In stumpy forms, a tyrosine phosphatase (TbPTP1) (Szoor
et al., 2006) prevents cells from differentiation until its activity
is reduced in the presence of the developmental triggers CCA
(Brun and Schonenberger, 1981), whose uptake is controlled by
the carboxylate transporter PAD proteins (Dean et al., 2009), as
detailed earlier. Recently, a D×D× T phosphatase, TbPIP39, was
identified as a downstream regulator of this pathway and shown
to be activated upon tyrosine-phosphorylation and, hence, neg-
atively regulated by TbPTP1 (Figure 3). Moreover, the presence
of TbPIP39 increased the activity of TbPTP1, reinforcing its own
repression and thereby generating a potentially bistable regula-
tory switch (Szoor et al., 2010). Importantly, this self-repressive
loop is interrupted and regulated by CCA, such that differenti-
ation can be initiated. Specifically, in the presence of CCA, the
activation of TbPTP1 by TbPIP39 is reduced, such that TbPIP39
becomes rapidly phosphorylated on tyrosine 278, the enzyme
activated and differentiation is stimulated (Szoor et al., 2010).
RNAi studies using stumpy form cells confirmed that reduc-
ing TbPIP39 levels inhibited differentiation, although delayed
differentiation remained possible probably through the inabil-
ity to completely eliminate TbPIP39 from the cells by RNAi.
Localization studies showed that TbPIP39 is found in glycosomes,
peroxisome-like organelles in trypanosomes, which are the site of
glycolysis and several other metabolic activities (Michels et al.,
2006). Supporting this, removal of the C-terminal glycosomal
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FIGURE 3 | Signaling pathways that drive differentiation when
trypanosomes enter the tsetse midgut. Citrate-cis aconitate (CCA) is
transported by cell membrane PAD proteins (a), this being favored under cold
shock conditions. CCA inhibits the activity of the differentiation inhibitor,
TbPTP1 (b) a tyrosine phosphatase whose activity is normally enhanced by its
substrate, TbPIP39. When TbPTP1 is inhibited, TbPIP39 becomes
phosphorylated and more active (c). TbPIP39 can relocate to the glycosome
(though this is not dependent upon its phosphorylation) whereupon it acts on
unidentified substrates to promote differentiation (d). The same signaling
pathway is stimulated by exposure of stumpy forms to mild acid conditions (pH
5.5 for 2 h) (e), which also generates phosphorylated TbPIP39. Exposure of
stumpy forms to proteases at the cell surface (f) also stimulates differentiation,
but this does not involve TbPTP1 or TbPIP39 and operates through an
uncharacterized pathway (g) that may or may not involve the glycosome. It is
also not necessary for differentiation in the midgut of tsetse. A reduction of
environmental glucose (h) has also been suggested to initiate differentiation,
but reducing medium glucose 20-fold, or using the transport inhibitor phloretin,
does not cause the differentiation of stumpy forms to procyclic forms.
localization signal on TbPIP39 prevented its ability to promote
differentiation, highlighting that the glycosome is the important
site of action for the enzyme. Although the target(s) of TbPIP39
in the glycosome are unknown, as are the kinases that oppose its
action, developmental effects mediated through metabolic per-
turbation are already well known, particularly with respect to
their impact on surface protein expression (Morris et al., 2002;
Vassella et al., 2004).
Although PAD proteins transport CCA and TbPTP1/TbPIP39
regulatory cross talk is controlled by the levels of these differ-
entiation signals, trypanosomes have also been reported to be
able to differentiate to procyclic forms in response to a number
of other triggers. These include (i) mild acid treatment (Rolin
et al., 1998), (ii) exposure of the parasite surface to limited pro-
tease digestion (Yabu and Takayanagi, 1988; Hunt et al., 1994;
Sbicego et al., 1999) and (iii) a reduction of glucose, mediated
either through the use of glucose-depleted media (Milne et al.,
1998), or exposure to phloretin, an inhibitor of glucose uptake
(Haanstra et al., 2011). With the identification of phosphorylated
TbPIP39 as a signature of differentiation stimulated via TbPTP1,
it has been possible to investigate, firstly, the efficiency of each
of these reported stimuli on transmissible stumpy forms and,
secondly, whether each signal is transduced through the same
signaling pathway (Szoor et al., 2013).
These studies revealed that CCA, mild acid and protease
treatment of stumpy forms could all stimulate differentiation
effectively, but that glucose depletion could not. This was a
surprising finding, since glucose levels are believed to rapidly
decrease in the tsetse blood meal. With respect to the signal-
ing pathways used, monitoring the phosphorylation of TbPIP39
using a phospho-specific antibody revealed that CCA and mild
acid both signal via the TbPTP1/TbPIP39 pathway, whereas pro-
tease treatment of the cells does not. Supporting the existence of
distinct signaling pathways, ablation of TbPIP39 by RNAi reduced
differentiation in response to CCA andmild acid but not protease
treatment.
Since protease attack of the parasite surface is believed to occur
in the tsetse midgut through the action of trypsin-like activities,
the relevance of trypsin like activities in parasite differentiation in
the tsetse fly has been recently investigated (Szoor et al., 2013). By
feeding stumpy form parasites in the presence of Soybean trypsin
inhibitor (STI), tsetse midgut trypsin activity could be almost
completely ablated. Despite this, no difference in trypanosome
differentiation was observed between control and treated tsetse
flies, with equivalent levels of procyclic forms being generated
in both populations. This highlighted that trypsin-like activities
in the tsetse midgut are not solely responsible for the initia-
tion of differentiation, although a contributory role for these
activities remains possible. Supporting this, in vitro exposure of
bloodstream trypanosomes to both CCA and protease treatment
generates a more robust differentiation response than exposure
to either trigger alone (Sbicego et al., 1999), suggesting that the
two signals could act co-operatively to ensure effective parasite
differentiation upon entry to the tsetse fly.
These findings support a central role for the CCA/PAD/
TbPTP1/TbPIP39 signaling pathway in regulating differentiation
both in vitro and in vivo, with protease attack of the para-
site surface being dispensable for differentiation in the tsetse
fly. Apparently, therefore, independent and redundant signaling
pathways can operate to control parasite development.
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PHENOTYPIC SCREENING FOR STUMPY FORMATION VIA
SMALL COMPOUND SCREENS
As well as providing fundamental biological insight into the
developmental pathways operating in these evolutionarily ancient
eukaryotes, analyses of the differentiation of trypanosomatids,
particularly in the mammalian bloodstream, provides possible
drug targets and approaches with the potential to limit the vir-
ulence or transmission of these important pathogens. The need
for new, safe, efficacious drugs to target African trypanosomiasis
is clear (Barrett et al., 2007; Simarro et al., 2012) and considerable
efforts are currently underway to identify new therapeutics. The
traditional route to identify such therapeutic agents has been to
search for compounds that will target genes or pathways neces-
sary for cell viability. Indeed, whole-cell based high-throughput
screening for trypanostatic and trypanocidal agents is well estab-
lished (Hesse et al., 1995; Mackey et al., 2006; Sykes and Avery,
2009; Jones et al., 2010; De Rycker et al., 2012; Sykes et al.,
2012; Vodnala et al., 2013) and multiple classes of compounds
with potential for development into new therapeutics are being
pursued (Mackey et al., 2006; Jones et al., 2010; Sykes et al.,
2012; Vodnala et al., 2013). However, phenotypic screens for
genes or pathways involved in the establishment, maintenance or
transmission of infection could provide an alternative or com-
plementary route to the identification of novel therapeutics with
anti-virulence or transmission-blocking potential. Indeed efforts
have been made for other pathogens to develop high through-
put phenotypic screens whereby small molecules are assessed for
their ability to enhance or hinder a biological function, rather
than cause direct cytotoxicity. This approach has the additional
benefit that compounds perturbing defined cellular processes can
provide invaluable tools for pathway dissection.
There are several examples of phenotypic screens that pro-
vide a template for dissecting virulence, transmission or other
important pathways in pathogens. For example, screens targeting
virulence factors in microbes have been used to identify com-
pounds that prevent Type III (Kauppi et al., 2003) or Type IV
(Paschos et al., 2011) secretion pathways in pathogenic gram-
negative bacteria. Similarly, a compound that reduces adhesion
of pathogenic fungi to mammalian epithelial cells was iden-
tified through screening for small molecules that block GPI-
mannoprotein (e.g., fungal adhesins, where the GPI is removed
and the protein linked to β-1,6-glucan) localization to the cell
wall (Tsukahara et al., 2003). Such concepts have been also
applied to protozoan parasites such as Toxoplasma gondii and
Plasmodium falciparum. During infection, the malaria parasite
P. falciparum uses multiple pathways for establishment, propaga-
tion, and maintenance of the parasitaemia and chemical genetic
approaches have aided in the understanding of these processes.
For example, a small screen of chemical protease inhibitors tar-
geting the Falcipain-1 protease from cell lysate was then extended
in whole cell assays to identify the role of this protease in red
blood cell (RBC) invasion by merozoite forms (Greenbaum et al.,
2002). This provided both increased understanding of the inva-
sion process as well as a potential new antimalarial able to prevent
merozoites from entering RBCs, thereby leaving them exposed
to the host immune system. Additionally, protease inhibitors
that prevent RBC rupture by P. falciparum have been identified
through a high-throughput, whole-cell chemical screen, leading
to the identification of two proteases, DPAP3 and PfSUB1, which
function in release of the parasite from the host cell (Arastu-
Kapur et al., 2008). As with Plasmodium, the parasite T.gondii
must also invade host cells in order to establish and maintain
an infection, requiring pathways for gliding motility, attachment
to the host cell, secretion from the micronemes and invasion.
Consequently, T.gondii invasion has been the target of multiple
whole-cell high throughput small molecule screens (Carey et al.,
2004; Hall et al., 2011; Kamau et al., 2012). These have suc-
cessfully identified compounds targeting different parts of this
pathway leading through follow up analysis to improved under-
standing of myosin motor activity during motility in one case
(Heaslip et al., 2010) and to identification of the DJ-1 pro-
tein, required for microneme secretion and motility in another
(Hall et al., 2011).
Clearly, the developmental biology of trypanosomes in the
mammalian bloodstream offers similar possibilities for pheno-
typic screens. Without the slender form, the trypanosome par-
asitaemia could not be established or maintained whereas the
stumpy form is necessary for cyclical transmission. As such, tar-
geting either stage could eliminate the parasite or block its spread.
For example, identification of compounds able to prevent slen-
der cell proliferation or switching of the VSG coat would result in
clearance of the parasites by the host immune system. Similarly,
identification of compounds that drive proliferative slender forms
to non-proliferative stumpy forms, or onward to procyclic forms,
if irreversible and complete, would cause clearance of the par-
asitaemia altogether. Indeed, even if only partial induction of
the population was achieved, this could lower the parasitaemia
below the threshold needed for tsetse transmission, both reduc-
ing virulence and transmission potential possibly providing an
adjunctive therapy for conventional trypanocidal drugs. In con-
trast, compounds able to prevent the slender to stumpy transition,
perhaps through blocking of density sensing or operation of the
stumpy induction pathway, would result in uncontrolled growth
within the host. Whilst this would reduce transmission potential,
it would significantly promote virulence and so would not be of
therapeutic value.
In order to carry out a phenotypic chemical screen an assay
must be designed that allows monitoring of the presence or
absence of the phenotype in a simple, cheap and high-throughput
manner, often through the use of a marker or reporter protein as
a proxy for that phenotype. For developmental studies, molecular
markers are known for the different life stages and reporter genes
and assays are commonly utilized in the study of trypanosome
molecular biology. For example, genetically modified reporter
lines that combine a reporter gene with the stumpy-enriched
PAD1 or ESAG9 3′UTR have been demonstrated to report on
stumpy formation in vitro (MacGregor and Matthews, 2012;
Monk et al., 2013) and such constructs can be modified in simple
assays to screen for chemical inducers of this differentiation event
(MacGregor and Matthews, unpublished data). Notwithstanding
the caution that the monomorphic cells usually employed in high
throughput screens may not reflect the phenotypic responses and
drug sensitivities of the more field relevant pleomorphic lines, it
is clear that screening for developmental defects in trypanosomes
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has potential for identifying novel anti-trypanosomal compounds
and useful tool compounds for biological research.
SUMMARY AND PERSPECTIVES
The last few years have provided the first molecular insight into
how trypanosomes monitor their environment and prepare for
transmission as stumpy forms. Moreover, their environmental
signaling pathways are now being uncovered in a coherent anal-
ysis that differs from the individual identification of molecules
possible through earlier candidate gene analysis. This has been
enabled through integration of information provided by high
throughput transcriptome and proteomic analyses and through
the capacity to extend out from identified nodes where key
molecules have been identified using protein interaction studies.
However, recently, the development of genome-wide RNAi selec-
tion approaches (Alsford et al., 2011, 2012) is providing a step
change in the information that is available onmolecular processes
in trypanosomes. Although initially focused on understanding
drug action, these screens have the potential to uncover the
molecular components of developmental pathways or gene regu-
latory networks, particularly where the developmental expression
of markers can be exploited to drive selectional screens. To date
the application of these screens has been limited to monomorphic
lines since their transfection efficiency is higher than the more
biologically relevant pleomorphic lines that are crucial to under-
standing the developmental biology of trypanosomes in their
mammalian host. However, as transfection efficiencies improve
(MacGregor et al., 2013), RNAi screens will become tractable in
pleomorphs and detailed analysis of slender and stumpy form
biology will become possible. The application of increased HTS
is also a powerful development for both anti-virulence therapies
and for dissecting the biology of trypanosome development in
its mammalian host. For example, the consequences of particu-
lar therapeutic or genetic perturbations can now be analyzed on a
genome-wide scale through a combination of transcriptome, pro-
teomic, and phosphoproteomic/post-translational modification
analyses. The greatly reduced cost of genome sequencing also now
means that different parasite strains can be economically ana-
lyzed, such that monomorphic laboratory-adapted lines can be
compared with pleomorphic laboratory and field strains, assist-
ing the identification of selected traits that render cells resistant
to the stumpy formation signal.
What key aspects of the development of trypanosomes in
the mammalian blood remain to be answered? One aspect is
the nature of the signal that the trypanosome uses to regulate
stumpy formation. Although a SIF or factors has been proposed,
it remains the “Loch Ness monster” of trypanosome research,
despite 15 years of effort. This failure could reflect several issues.
Firstly, until recently, suitable reporter assays were not available to
detect SIF activity, restricting the capacity to carry out bioassays.
The development of PAD-based reporters to monitor stumpy for-
mation (MacGregor and Matthews, 2012) provides the solution
to this problem, applicable also to HTS for anti virulence com-
pounds as detailed above. Secondly, SIF may not be a single entity,
but a composite of several co-dependent signals that confound
simple purification regimens. In bacterial QS, for example, multi-
ple signals are often used to help the bacterial population perceive
cell density in context- for example where there are low or high
flow conditions that would change the “interpretation” of a single
soluble signal (Diggle et al., 2007). Thirdly, the behavior of pleo-
morphic cells in culture does not fully reflect their behavior in
mice, since parasites grown in liquid culture without methyl cel-
lulose (unlike those on plates) do not form uniformly cell-cycle
arrested stumpy forms despite their continued ability to readily
undergo this transition in vivo. Finally, the evidence for an accu-
mulated signal in stumpy formation remains circumstantial and
indirect, such that a perception of depletion of a key environ-
mental component is not yet formally excluded. In each case, the
metabolomics-guided refinement of trypanosome culture media
and the ability to detect subtle changes inmedia composition after
parasite conditioning by small molecule profiling (Creek et al.,
2013) provides one route to narrow down the entities that may
control density sensing.
The response of the parasite to density sensing also needs to
be dissected in detail. In particular, identification of the molec-
ular components of the SIF reception pathway is tractable and
offers the opportunity to generate a coherent picture of a key try-
panosome environmental signaling pathway, providing detailed
insight into how the parasite interacts with its environment. Upon
entering the tsetse fly also, the environmental signaling pathways
are being assembled, the link to regulation through the glyco-
somes (Szoor et al., 2010) providing an exciting area of metabolic
control that could generate wide-ranging changes to the parasites’
physiology, adapting them to life in the tsetse midgut.
As these perception and response pathways become charac-
terized and central regulators identified, therapeutic opportuni-
ties will certainly emerge. Parasite-specific essential proteins will
provide novel drug targets, whereas the density-sensing mecha-
nisms provide opportunities for perturbing signal transduction
or manipulating the quorum-sensing signal. This represents an
area of considerable interest inmicrobial therapeutics, since inter-
fering with communication betweenmicrobes can generate imag-
inative therapeutic approaches whereby pathogen signals can be
manipulated to block virulence under conditions where resistance
is selected against (Brown et al., 2009). Clearly, the developmental
events that underpin the pre-adaptation of trypanosomes for life
in the tsetse fly provides a rich seam of exciting biology, molecular
biology and therapeutic potential that will sustain trypanosome
researchers, and excite the wider biological community, for many
years to come.
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